Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Blaise

Showing results (41-50 of 510) with videos related to

Pageof 51
Sort By:
Leukemia & Lymphoma|July 16, 2010
Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantJean El-Cheikh, Luca Castagna, Ling Wang, et al.
Blood|January 13, 2004
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemiaMohamad Mohty, Eric Jourdan, Naira Ben Mami, et al.
Cancer|October 20, 2010
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative studyThomas Prebet, Anne Etienne, Raynier Devillier, et al.
Leukemia & Lymphoma|January 12, 2016
Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplantColombe Saillard, Jean El Cheikh, Angela Granata, et al.
Transfusion|April 26, 2005
Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMateClaude Lemarie, Boris Calmels, Carine Malenfant, et al.
Bone Marrow Transplantation|June 25, 2026
Sequential CLAGE-Ven (cladribine, cytarabine, etoposide, and venetoclax) with reduced-intensity conditioning improves outcomes in patients with refractory acute myeloid leukemia: a prospective phase II studyWen-Hui Gao, Chu-Ran Wang, Li-Ning Wang, et al.
Frontiers in Medicine|April 25, 2022
Clinical Significance of Haplo-Fever and Cytokine Profiling After Graft Infusion in Allogeneic Stem Cell Transplantation From Haplo-Identical DonorsLining Wang, Bo Dai, Wenhui Gao, et al.
Blood|September 6, 2005
Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Didier Blaise, Catherine Faucher, et al.
Bone Marrow Transplantation|June 19, 2026
Time to resolution of veno-occlusive disease/sinusoidal obstruction syndrome post-HCT in defibrotide-treated adults from two European registriesMohamad Mohty, Régis Peffault de Latour, Myriam Labopin, et al.
Leukemia & Lymphoma|December 21, 2013
Evaluation of comorbidity indexes in the outcome of elderly patients treated for acute lymphoblastic leukemiaColombe Saillard, Anne Etienne, Aude Charbonnier, et al.
Pageof 51

Showing results (41-50 of 510) with videos related to

Sort By:
Pageof 51
Leukemia & Lymphoma|July 16, 2010
Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantJean El-Cheikh, Luca Castagna, Ling Wang, et al.
Blood|January 13, 2004
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemiaMohamad Mohty, Eric Jourdan, Naira Ben Mami, et al.
Cancer|October 20, 2010
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative studyThomas Prebet, Anne Etienne, Raynier Devillier, et al.
Leukemia & Lymphoma|January 12, 2016
Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplantColombe Saillard, Jean El Cheikh, Angela Granata, et al.
Transfusion|April 26, 2005
Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMateClaude Lemarie, Boris Calmels, Carine Malenfant, et al.
Bone Marrow Transplantation|June 25, 2026
Sequential CLAGE-Ven (cladribine, cytarabine, etoposide, and venetoclax) with reduced-intensity conditioning improves outcomes in patients with refractory acute myeloid leukemia: a prospective phase II studyWen-Hui Gao, Chu-Ran Wang, Li-Ning Wang, et al.
Frontiers in Medicine|April 25, 2022
Clinical Significance of Haplo-Fever and Cytokine Profiling After Graft Infusion in Allogeneic Stem Cell Transplantation From Haplo-Identical DonorsLining Wang, Bo Dai, Wenhui Gao, et al.
Blood|September 6, 2005
Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Didier Blaise, Catherine Faucher, et al.
Bone Marrow Transplantation|June 19, 2026
Time to resolution of veno-occlusive disease/sinusoidal obstruction syndrome post-HCT in defibrotide-treated adults from two European registriesMohamad Mohty, Régis Peffault de Latour, Myriam Labopin, et al.
Leukemia & Lymphoma|December 21, 2013
Evaluation of comorbidity indexes in the outcome of elderly patients treated for acute lymphoblastic leukemiaColombe Saillard, Anne Etienne, Aude Charbonnier, et al.
Pageof 51